Brain, Vol. 119, No. 2, 457-463, 1996
© 1996 Oxford University Press
research-article |
Cerebrospinal fluid from multiple sclerosis patients inactivates neuronal Na+ current
Heinrich–Heine University, Department of Neurology Düsseldorf, Germany
Correspondence to:
Correspondence to: Dr H. Köller, Heinrich-Heine University, Department of Neurology, PO Box 10 10 07, D-40001 Düsseldorf, Germany
Multiple sclerosis is a common inflammatory disease of the CNS. A great number of immunologically active molecules have been identified in the CSF of these patients (CSF-MS), but the role of these substances in neuronal dysfunction, especially in the origin of transient symptoms, is unclear. Therefore, we investigated the effect of CSF from 13 multiple sclerosis patients on membrane currents of cultured cortical neurons from embryonic rat and compared it with the effect of CSF from 12 patients with non-inflammatory neurological diseases. We found an increase in Na+ current (INa) inactivation by a shift of the h
curve to more hyperpolarizing potentials by 9.3 mV. This effect was reversible by washing and could be abolished by CSF-MS heat inactivation. The degree of the shift ranged from 4.3 mV to 17.6 mV and correlated with the IgG index, but not with the degree of pleocytosis, protein or albumin content. The maximal amplitude of INa was unchanged. We concluded that diffusible factors are released into the CSF which reduce neuronal excitability and thereby disturb the function of the neuronal network These factors may well contribute to transient neurological symptoms seen in patients with ‘active’ multiple sclerosis.
multiple sclerosis; sodium current; neuronal cell culture; cerebrospinal fluid; cytokines
Received May 5, 1995. Revised October 2, 1995. Accepted November 19, 1995.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. De Stefano, S. Narayanan, P. M. Matthews, G. S. Francis, J. P. Antel, and D. L. Arnold In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis Brain, October 1, 1999; 122(10): 1933 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tourbah, J. L. Stievenart, O. Gout, B. Fontaine, R. Liblau, C. Lubetzki, E. A. Cabanis, and O. Lyon-Caen Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis Neurology, September 1, 1999; 53(5): 1091 - 1091. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Mastronardo, M. A. Rocca, G. Iannucci, C. Pereira, and M. Filippi A Longitudinal MR Study of the Presymptomatic Phase in a Patient with Clinically Definite Multiple Sclerosis AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1268 - 1272. [Abstract] [Full Text]
|
|